Literature DB >> 23079638

Insights from molecular dynamics: the binding site of cocaine in the dopamine transporter and permeation pathways of substrates in the leucine and dopamine transporters.

Bonnie A Merchant1, Jeffry D Madura.   

Abstract

The dopamine transporter (DAT) facilitates the regulation of synaptic neurotransmitter levels. As a target for therapeutic and illicit psycho-stimulant drugs like antidepressants and cocaine, DAT has been studied intensively. Despite a wealth of mutational and physiological data regarding DAT, the structure remains unsolved and details of the transport mechanism, binding sites and conformational changes remain debated. A bacterial homolog of DAT, the leucine transporter (LeuT(Aa)) has been used as a template and framework for modeling and understanding DAT. Free energy profiles obtained from Multi-Configuration Thermodynamic Integration simulations allowed us to correctly identify the primary and secondary binding pockets of LeuT(Aa). A comparison of free energy profiles for dopamine and cocaine in DAT suggests that the binding site of cocaine is located in a secondary pocket, not the primary substrate site. Two recurring primary pathways for intracellular substrate release from the primary pocket are identified in both transporters using the Random Acceleration Molecular Dynamics method. One pathway appears to follow transmembranes (TMs) 1a and 6b while the other pathway follows along TMs 6b and 8. Interestingly, we observe that a single sodium ion is co-transported with leucine during both simulation types.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23079638      PMCID: PMC3547672          DOI: 10.1016/j.jmgm.2012.05.007

Source DB:  PubMed          Journal:  J Mol Graph Model        ISSN: 1093-3263            Impact factor:   2.518


  63 in total

Review 1.  Force fields for protein simulations.

Authors:  Jay W Ponder; David A Case
Journal:  Adv Protein Chem       Date:  2003

2.  Enzymatic Hydroxylation in p-Hydroxybenzoate Hydroxylase:  A Case Study for QM/MM Molecular Dynamics.

Authors:  Hans Martin Senn; Stephan Thiel; Walter Thiel
Journal:  J Chem Theory Comput       Date:  2005-05       Impact factor: 6.006

3.  The mechanism of a neurotransmitter:sodium symporter--inward release of Na+ and substrate is triggered by substrate in a second binding site.

Authors:  Lei Shi; Matthias Quick; Yongfang Zhao; Harel Weinstein; Jonathan A Javitch
Journal:  Mol Cell       Date:  2008-06-20       Impact factor: 17.970

4.  A multisubstrate mechanism of striatal dopamine uptake and its inhibition by cocaine.

Authors:  J S McElvain; J O Schenk
Journal:  Biochem Pharmacol       Date:  1992-05-28       Impact factor: 5.858

5.  Ligand entry and exit pathways in the beta2-adrenergic receptor.

Authors:  Ting Wang; Yong Duan
Journal:  J Mol Biol       Date:  2009-08-06       Impact factor: 5.469

6.  Simple allosteric model for membrane pumps.

Authors:  O Jardetzky
Journal:  Nature       Date:  1966-08-27       Impact factor: 49.962

7.  X-ray structures of LeuT in substrate-free outward-open and apo inward-open states.

Authors:  Harini Krishnamurthy; Eric Gouaux
Journal:  Nature       Date:  2012-01-09       Impact factor: 49.962

8.  Mechanism for cocaine blocking the transport of dopamine: insights from molecular modeling and dynamics simulations.

Authors:  Xiaoqin Huang; Howard H Gu; Chang-Guo Zhan
Journal:  J Phys Chem B       Date:  2009-11-12       Impact factor: 2.991

9.  Antidepressant binding site in a bacterial homologue of neurotransmitter transporters.

Authors:  Satinder K Singh; Atsuko Yamashita; Eric Gouaux
Journal:  Nature       Date:  2007-08-08       Impact factor: 49.962

10.  Cationic interactions at the human dopamine transporter reveal binding conformations for dopamine distinguishable from those for the cocaine analog 2 alpha-carbomethoxy-3 alpha-(4-fluorophenyl)tropane.

Authors:  Nianhang Chen; LingLing Sun; Maarten E A Reith
Journal:  J Neurochem       Date:  2002-06       Impact factor: 5.372

View more
  7 in total

1.  Structural dynamics of the monoamine transporter homolog LeuT from accelerated conformational sampling and channel analysis.

Authors:  James R Thomas; Patrick C Gedeon; Jeffry D Madura
Journal:  Proteins       Date:  2014-05-09

2.  Properties of an inward-facing state of LeuT: conformational stability and substrate release.

Authors:  Julie Grouleff; Siri Søndergaard; Heidi Koldsø; Birgit Schiøtt
Journal:  Biophys J       Date:  2015-03-24       Impact factor: 4.033

3.  Computational and biochemical docking of the irreversible cocaine analog RTI 82 directly demonstrates ligand positioning in the dopamine transporter central substrate-binding site.

Authors:  Rejwi Acharya Dahal; Akula Bala Pramod; Babita Sharma; Danielle Krout; James D Foster; Joo Hwan Cha; Jianjing Cao; Amy Hauck Newman; John R Lever; Roxanne A Vaughan; L Keith Henry
Journal:  J Biol Chem       Date:  2014-08-31       Impact factor: 5.157

4.  Changes in dopamine transporter binding in nucleus accumbens following chronic self-administration cocaine: heroin combinations.

Authors:  Lindsey P Pattison; Scot McIntosh; Tammy Sexton; Steven R Childers; Scott E Hemby
Journal:  Synapse       Date:  2014-06-19       Impact factor: 2.562

Review 5.  Insights to ligand binding to the monoamine transporters-from homology modeling to LeuBAT and dDAT.

Authors:  Heidi Koldsø; Julie Grouleff; Birgit Schiøtt
Journal:  Front Pharmacol       Date:  2015-09-24       Impact factor: 5.810

Review 6.  Monoamine transporters: insights from molecular dynamics simulations.

Authors:  Julie Grouleff; Lucy Kate Ladefoged; Heidi Koldsø; Birgit Schiøtt
Journal:  Front Pharmacol       Date:  2015-10-16       Impact factor: 5.810

7.  The Environment Shapes the Inner Vestibule of LeuT.

Authors:  Azmat Sohail; Kumaresan Jayaraman; Santhoshkannan Venkatesan; Kamil Gotfryd; Markus Daerr; Ulrik Gether; Claus J Loland; Klaus T Wanner; Michael Freissmuth; Harald H Sitte; Walter Sandtner; Thomas Stockner
Journal:  PLoS Comput Biol       Date:  2016-11-11       Impact factor: 4.779

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.